Bank Of New York Mellon Corp Agios Pharmaceuticals, Inc. Transaction History
Bank Of New York Mellon Corp
- $521 Trillion
- Q1 2024
A detailed history of Bank Of New York Mellon Corp transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Bank Of New York Mellon Corp holds 195,958 shares of AGIO stock, worth $7.12 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
195,958
Previous 203,761
3.83%
Holding current value
$7.12 Million
Previous $4.54 Billion
26.27%
% of portfolio
0.0%
Previous 0.0%
Shares
26 transactions
Others Institutions Holding AGIO
# of Institutions
207Shares Held
60MCall Options Held
365KPut Options Held
457K-
Farallon Capital Management LLC San Francisco, CA5.59MShares$203 Million0.76% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.57MShares$202 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.66MShares$169 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V84.01MShares$146 Million1.84% of portfolio
-
State Street Corp Boston, MA3.14MShares$114 Million0.0% of portfolio
About AGIOS PHARMACEUTICALS, INC.
- Ticker AGIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,818,000
- Market Cap $1.99B
- Description
- Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...